BTG plc announced that the FDA has approved Varithena (polidocanol injectable foam) for the treatment of patients with incompetent veins and visible varicosities of the great saphenous vein (GSV) ...

BTG has finally got the green light in the USA for Varithena, the UK group's varicose veins treatment. BTG has finally got the green light in the USA for Varithena, the UK group’s varicose veins ...

British pharmaceutical firm BTG has announced the arrival of a new treatment for varicose veins. The company’s product, Varithena, offers a minimally invasive treatment that is capable of dissolving ...

BTG plc (LSE: BTG), the specialist healthcare company, today announces that the US Food and Drug Administration (FDA) has approved Varithena™ (polidocanol injectable foam) for the treatment of ...

BTG plc: FDA approves Varithena™ (polidocanol injectable foam) for the treatment of patients with varicose veins London, UK, 26 November 2013: BTG plc (LSE: BTG), the specialist healthcare company, ...

The US Food and Drug Administration (FDA) has approved BTG's Varithena (polidocanol injectable foam) for the treatment of patients with incompetent veins and visible varicosities of the great ...

WEST CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--BTG plc (LSE:BTG), the specialist healthcare company, announced that the U.S. Food and Drug Administration has approved an extension of the post-activation ...

FREDERICKSBURG, Texas, Jan. 14, 2020 /PRNewswire-PRWeb/ -- Varicose vein treatment is the latest addition to the medical offerings from board-certified specialist, Robin Fleck, MD, founder and medical ...

BTG plc (LSE: BTG), the specialist healthcare company, today announces that Health Canada has issued a Notice of Compliance approving Varithena™ (polidocanol injectable foam), a prescription medicine ...

LONDON--BTG PLC (BTG.LN) on Tuesday reported lower annual pretax profit, though it noted a steady increase in demand for its varicose vein treatment, Varithena. The drug group said pretax profit in ...